FDA last week told labs they could combine and test multiple patient COVID-19 diagnostic test samples using a new “pooling” technique laid out by the agency in a set of updated testing templates , coming just days before National Institute of Allergy and Infectious Diseases Director Anthony Fauci told The Washington Post that health officials were having “intense discussions” about pivoting to the new testing approach. Using the pooling technique, developers can combine several patient samples into one batch...